Details for New Drug Application (NDA): 050207
✉ Email this page to a colleague
The generic ingredient in ERYPED is erythromycin ethylsuccinate. There are one hundred and three drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the erythromycin ethylsuccinate profile page.
Summary for 050207
Tradename: | ERYPED |
Applicant: | Azurity |
Ingredient: | erythromycin ethylsuccinate |
Patents: | 0 |
Pharmacology for NDA: 050207
Physiological Effect | Decreased Sebaceous Gland Activity |
Medical Subject Heading (MeSH) Categories for 050207
Suppliers and Packaging for NDA: 050207
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
E.E.S. | erythromycin ethylsuccinate | GRANULE;ORAL | 050207 | NDA | Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals) | 24338-130 | 24338-130-13 | 100 mL in 1 BOTTLE (24338-130-13) |
E.E.S. | erythromycin ethylsuccinate | GRANULE;ORAL | 050207 | NDA | Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals) | 24338-132 | 24338-132-13 | 100 mL in 1 BOTTLE (24338-132-13) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | GRANULE;ORAL | Strength | EQ 200MG BASE/5ML | ||||
Approval Date: | Approved Prior to Jan 1, 1982 | TE: | AB | RLD: | Yes |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | GRANULE;ORAL | Strength | EQ 400MG BASE/5ML | ||||
Approval Date: | Approved Prior to Jan 1, 1982 | TE: | AB | RLD: | Yes |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | GRANULE;ORAL | Strength | EQ 200MG BASE/5ML | ||||
Approval Date: | Mar 30, 1987 | TE: | AB | RLD: | Yes |
Complete Access Available with Subscription